Tetsuhiro Yoshinami
5PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 23, 2025
Correction: Real‑world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first‑ or second‑line treatment for hormone receptor-positive, HER2‑negative advanced or metastatic breast cancer.Tetsuhiro Yoshinami, Yuko Takano, Yukinori Ozaki
|May 20, 2025
Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.Tetsuhiro Yoshinami, Yuko Takano, Yukinori Ozaki
|May 19, 2025
Real-world evidence of febrile neutropenia-related hospitalization on patients with perioperative chemotherapy for early breast cancer in Japan.Tetsuhiro Yoshinami, Nobuhiro Shibata, Kentaro Tamaki
|Jan 24, 2025
Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis.Yutaka Yamamoto, Hiroji Iwata, Shigehira Saji
Pageof 1
Frequent Collaborators
3 joint publications
Nobuhiro Shibata
3 joint publications
Shigehira Saji
3 joint publications
Norikazu Masuda
3 joint publications
Satoshi Morita
2 joint publications
Masahiro Takada
2 joint publications
Yuko Takano
2 joint publications
Nobuyuki Tsunoda
2 joint publications
Shinji Ohno
1 joint publications
Takayuki Ueno
1 joint publications
Toshimi Takano
